北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer
作者: Liu, P.; Yang, D. Q.; Xie, F.; Zhou, B.; Liu, M.
关键词: Calcitonin ; Bone pain ; Anastrozole ; Breast cancer ; Aromatase inhibitor
刊名: GENETICS AND MOLECULAR RESEARCH
发表日期: 2014
DOI: 10.4238/2014.July.24.7
卷: 13, 期:3, 页:5285-5291
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Biochemistry & Molecular Biology ; Genetics & Heredity
研究领域[WOS]: Biochemistry & Molecular Biology ; Genetics & Heredity
关键词[WOS]: POSTOPERATIVE ADJUVANT CHEMOTHERAPY ; PROSTATE-CANCER ; OSTEOPOROSIS ; MANAGEMENT ; EFFICACY ; HORMONE
英文摘要:

This study aimed to investigate calcitonin as an effective therapy for osteoporosis in patients with bone pain during the anastrozole treatment of breast cancer. Ninety-one patients, who were on anastrozole treatment for breast cancer and also suffered anastrozole-induced bone pain, were randomly divided into two groups: the calcitonin group received salmon calcitonin and Caltrate D, and the control group received Caltrate D. All patients were evaluated by the visual analogue scale (VAS) and underwent the dual energy x-ray absorptiometry test for bone mineral density (BMD), and serum osteocalcin (BGP), alkaline phosphatase (ALP), calcium (Ca), and phosphorus (P) were measured at three months before and after the treatment. Significant differences in serum Ca, P, BGP, and ALP were found in each group between before and after treatment (P < 0.05), while no differences between the calcitonin and control groups were found. No difference was observed in femur BMD between the two groups, or between before and after treatment in each group. There was a significant difference in spine BMD between before and after treatment in the control group (P < 0.05) but not in the calcitonin group, while no difference was found between the calcitonin and control groups. Futhermore, VAS score significantly declined in each group after treatment (P < 0.05), but much more in the calcitonin group than the control group (P < 0.05). Our finding suggests that calcitonin may alleviate bone pain during the anastrozole treatment of breast cancer but has no effect on bone loss during cancer treatment.

语种: 英语
项目资助者: Astrazeneca
WOS记录号: WOS:000340383600061
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51472
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Peoples Hosp, Dept Surg IV, Beijing 100871, Peoples R China

Recommended Citation:
Liu, P.,Yang, D. Q.,Xie, F.,et al. Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer[J]. GENETICS AND MOLECULAR RESEARCH,2014,13(3):5285-5291.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Liu, P.]'s Articles
[Yang, D. Q.]'s Articles
[Xie, F.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Liu, P.]‘s Articles
[Yang, D. Q.]‘s Articles
[Xie, F.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace